Deutsche Bank’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
Deutsche Bank's AGL Position: Q3 2026 in Review
Deutsche Bank reduced its Agilon Health (AGL) stake by 6.5% in Q3 2026, selling an estimated $83.6K and leaving 12,322 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #2237.
Deutsche Bank first reported a position in AGL in Q2 2021 and has held it in 22 quarters since. The position peaked at $32.7M in Q4 2021. 180 funds tracked by Wall St. Rank hold AGL as of Q3 2026.
- Deutsche Bank held 12,322 shares of Agilon Health worth $981K as of Q3 2026.
- Deutsche Bank sold 859 Agilon Health shares in Q3 2026, an estimated $83.6K.
- Agilon Health made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2237 holding.
- Deutsche Bank first reported a position in Agilon Health in Q2 2021 and has held it in 22 quarters since.
- Deutsche Bank's Agilon Health position peaked at $32.7M in Q4 2021.
- 180 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.